Patent · US Active

Prodrugs and drug-macromolecule conjugates having controlled drug release rates

US8680315B2 · kind B2 · utility

4Cited by

2References

18Claims

0Family size

Assignee

PROLYNX LLC · US

Inventors

Daniel V. Santi · San Francisco, US
Gary Ashley · Alameda, US

Key dates

Filing date	Jun 26, 2009
Grant date	Mar 25, 2014
Priority date	—
Expiry date	Oct 27, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC08L2203/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides methods and compositions that permit controlled and prolonged drug release in vivo. The compounds are either prodrugs with tunable rates of release, or conjugates of the drug with macromolecules which exhibit tunable controlled rates of release.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.